Agios Pharmaceuticals

Celgene on biotech hunt with Agios, Jounce in crosshairs: FT
Celgene on biotech hunt with Agios, Jounce in crosshairs: FT
Fierce Biotech
Celgene
M&A
Agios Pharmaceuticals
Jounce Therapeutics
Flag link:
Agios spotlights promising data for IDH1 drug, putting it on the path to FDA submission
Agios spotlights promising data for IDH1 drug, putting it on the path to FDA submission
Endpoints
Agios Pharmaceuticals
ASH
FDA
IDH1
ivosidenib
Flag link:
Agios Pharma shares dive after anemia treatment development halted
Agios Pharma shares dive after anemia treatment development halted
Marketwatch
Agios Pharmaceuticals
clinical trials
AG-519
pyruvate kinase deficiency
Flag link:
3 Drugs Heading to the FDA Soon
3 Drugs Heading to the FDA Soon
Motley Fool
FDA
Kite Pharma
KTE-C19
Flexion
Zilretta
AG-221
Agios Pharmaceuticals
Celgene
Flag link:
5 Major Clinical Trial Results Coming Up
5 Major Clinical Trial Results Coming Up
24/7 Wall St
clinical trials
Vertex Pharmaceuticals
Orkambi
Puma Biotechnology
neratinib
GW Pharma
Epidiolex
Agios Pharmaceuticals
AG-348
AG-519
Dermira
DRM-04
Flag link:
Celgene expands partnership with Agios into immuno-oncology
Celgene expands partnership with Agios into immuno-oncology
BioPharma Dive
Celgene
Agios Pharmaceuticals
immuno-oncology
AG-120
Flag link:
Who Is Gilead Going To Buy?
Who Is Gilead Going To Buy?
Seeking Alpha
Gilead Sciences
M&A
Genfit
Intercept Pharma
Agios Pharmaceuticals
Ziopharm
Flag link:
Agios Pharma Plunges 15% Despite Strong Data for Leukemia Drug
Agios Pharma Plunges 15% Despite Strong Data for Leukemia Drug
Barron's
Agios Pharmaceuticals
AG-221
leukemia
Flag link:
Celgene's 3 Most Important Collaborations
Celgene's 3 Most Important Collaborations
Investopedia
Celgene
Agios Pharmaceuticals
OncoMed
MedImmune
Flag link:
A pair of Celgene partners gets on the FDA fast track
A pair of Celgene partners gets on the FDA fast track
Fierce Biotech
Celgene
FDA
fast track
luspatercept
Acceleron
beta-thalassemia
AG-120
Agios Pharmaceuticals
Flag link:
Agios Pharmaceuticals reports 4Q loss
Agios Pharmaceuticals reports 4Q loss
Yahoo/AP
Agios Pharmaceuticals
earnings
Flag link:
The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers
The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers
24/7 Wall St
Agios Pharmaceuticals
OvaScience
Radius
Prosensa
TG Therapeutics
Bluebird Bio
Receptos
Flag link:
Best and worst 2014 biotech performers on Wall Street
Best and worst 2014 biotech performers on Wall Street
Fierce Biotech
Avanir Pharmaceuticals
Agios Pharmaceuticals
TG Therapeutics
Bluebird Bio
Vivus
Agerion
Theravance
Flag link:
The Winners for Best and Worst Biotech CEOs of 2014 Are...
The Winners for Best and Worst Biotech CEOs of 2014 Are...
TheStreet.com
biotech
Bluebird Bio
Agios Pharmaceuticals
Flag link:
The Nominees for Best Biotechnology Co. CEO of 2014 Are...
The Nominees for Best Biotechnology Co. CEO of 2014 Are...
TheStreet.com
biotech
EXACT Sciences
Idenix
Prosensa
Agios Pharmaceuticals
Bluebird Bio
InterMune
Flag link:
These 4 Biotech Stocks Have Been On Fire
These 4 Biotech Stocks Have Been On Fire
Yahoo/Benzinga
Agios Pharmaceuticals
Achillion
Amicus Therapeutics
Orexigen
Flag link:
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
TheStreet.com
Agios Pharmaceuticals
Novartis
CAR-T
Celgene
Amgen
Merck
Bristol-Myers Squibb
Seattle Genetics
Sunesis
Flag link:
Hot Drugmakers Build More Labs, Grab Space In Boston
Hot Drugmakers Build More Labs, Grab Space In Boston
Investors.com
Boston
Biogen Idec
Baxter International
Agios Pharmaceuticals
Pfizer
Flag link:
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
TheStreet.com
Agios Pharmaceuticals
leukemia
AG-120
AML
Flag link:
Agios' Early Drug-Trial Report Cheers Wall Street
Agios' Early Drug-Trial Report Cheers Wall Street
Investors.com
Agios Pharmaceuticals
AG-120
Flag link:

Pages